Development of the prediction marker and the preemptive therapy for chronic GVHD based on abnormal B cell homeostasis during the acute phase of allogeneic HSCT
Development of the prediction marker and the preemptive therapy for chronic GVHD based on abnormal B cell homeostasis during the acute phase of allogeneic HSCT
批准号:
20K08753
负责人:
Matsuoka Ken-ichi
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2023-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Graft-versus-host disease: current understanding of immune pathogenesis and clinical treatment
移植物抗宿主病:免疫发病机制和临床治疗的最新认识
DOI:
10.11406/rinketsu.62.1281
发表时间:
2021
期刊:
Rinsho Ketsueki
影响因子:
--
作者:
[Yanada M, Konuma T, Yamasaki S, Mizuno S, Hirabayashi S, Nishiwaki S, Uchida N, Doki N, Tanaka M, Ozawa Y, Sawa M, Eto T, Kawakita T, Ota S, Fukuda T, Onizuka M, Kimura T, Atsuta Y, Kako S, Yano S, 松岡賢市]
通讯作者:
松岡賢市
GVHDの予防と治療の新たな展開
GVHD防治新进展
DOI:
--
发表时间:
2021
期刊:
臨床血液
影响因子:
--
作者:
[Yasu T, Konuma T, Oiwa-Monna M, Takahashi S, Nannya Y, Tojo A, 松岡賢市]
通讯作者:
松岡賢市
DOI:
10.1038/s41409-020-01100-0
发表时间:
2020-10-30
期刊:
BONE MARROW TRANSPLANTATION
影响因子:
4.8
作者:
[Iwamoto, Miki, Ikegawa, Shuntaro, Matsuoka, Ken-ichi]
通讯作者:
Matsuoka, Ken-ichi
Development of a novel algorithm for immune regulation that enables the active Treg amplification soon after HSCT
-
批准号:17K09954
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:Matsuoka Ken-ichi
-
依托单位: